A committee of subject matter experts established by the Comptroller General of Drugs of India (DCGI) to review COVID-19 vaccine proposals, recommended an “interim efficacy analysis for Covaxin.” The vaccine was developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR). The expert committee asked a …
Read More »Emergency approval not recommended for Covaxin; the panel asks for more data
